Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127869481 | 12786948 | 1 | I | 20160915 | 20160922 | 20160927 | 20160927 | EXP | US-ABBVIE-16P-163-1737813-00 | ABBVIE | 69.00 | YR | M | Y | 90.40000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127869481 | 12786948 | 1 | PS | ANDROGEL | TESTOSTERONE | 1 | Topical | UNKNOWN | 21015 | GEL | |||||||||
127869481 | 12786948 | 2 | SS | GS-9883IFTC!TAF | INVESTIGATIONAL PRODUCT | 1 | Oral | UNKNOWN | 0 | 1 | DF | TABLET | QD | ||||||
127869481 | 12786948 | 3 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 4 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 5 | SS | LASIX | FUROSEMIDE | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 6 | SS | CLARITIN | LORATADINE | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 7 | SS | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 8 | SS | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | Respiratory (inhalation) | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 9 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 10 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 11 | SS | ASPIRIN. | ASPIRIN | 1 | UNKNOWN | 0 | |||||||||||
127869481 | 12786948 | 12 | SS | NAPROSYN | NAPROXEN | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 13 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | UNKNOWN | 0 | ||||||||||
127869481 | 12786948 | 14 | SS | ABCIDTGI3TC (CODE NOT BROKEN) | ABACAVIR SULFATEDOLUTEGRAVIR SODIUMLAMIVUDINE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127869481 | 12786948 | 1 | Hypogonadism male |
127869481 | 12786948 | 2 | HIV infection |
127869481 | 12786948 | 3 | Dyspepsia |
127869481 | 12786948 | 4 | Atrial fibrillation |
127869481 | 12786948 | 5 | Diuretic therapy |
127869481 | 12786948 | 6 | Seasonal allergy |
127869481 | 12786948 | 7 | Asthma |
127869481 | 12786948 | 8 | Asthma |
127869481 | 12786948 | 9 | Neuropathy peripheral |
127869481 | 12786948 | 10 | Cardiovascular disorder |
127869481 | 12786948 | 11 | Atrial fibrillation |
127869481 | 12786948 | 12 | Neuropathy peripheral |
127869481 | 12786948 | 13 | Neuralgia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127869481 | 12786948 | HO |
127869481 | 12786948 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127869481 | 12786948 | Atrial fibrillation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127869481 | 12786948 | 1 | 2013 | 0 | ||
127869481 | 12786948 | 2 | 20160622 | 0 | ||
127869481 | 12786948 | 3 | 2010 | 0 | ||
127869481 | 12786948 | 4 | 20160906 | 0 | ||
127869481 | 12786948 | 5 | 20160914 | 0 | ||
127869481 | 12786948 | 6 | 2000 | 0 | ||
127869481 | 12786948 | 7 | 2013 | 0 | ||
127869481 | 12786948 | 8 | 2013 | 0 | ||
127869481 | 12786948 | 9 | 2013 | 0 | ||
127869481 | 12786948 | 10 | 2014 | 0 | ||
127869481 | 12786948 | 12 | 2013 | 0 | ||
127869481 | 12786948 | 13 | 2013 | 0 |